Horizon Scanning in Oncology – support for a budget-impact-calculation
As part of the Horizon Scanning in Oncology (HSO) project, a generic tool was developed in English to give support for a budget-impact-analysis of oncology drugs. This tool can therefore be used as assistance for a budget-impact-calculation in the HSO project but also in other fields of oncology. It represents a raw version, which can be expanded or modified for any particular drug to be evaluated, e.g. with regard to diagnostic tests, the most frequent side effects, etc.. The practicality of the tool is illustrated by means of an application example of the oncology drug palbociblib. Because of the varying patient populations, the percentage of the target population on the hospital level must be added in order to be able to calculate the total costs for the medicinal product.